Northwestern Medicine scientists have developed a method for identifying reactive cysteines on peptide antigens within the ...

It is possible to substantially enhance these antibodies’ therapeutic potential via humanization, effectively reducing ...

Boster Biological Technology is revolutionizing molecular biology with its advanced recombinant protein expression and custom ...

Recombinant antibody technology has helped address many problems associated with hybridoma platforms, opening the door to a ...

A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has ...

Rheumatoid factor (RF) is a type of antibody, an immune system protein that helps the body fight foreign substances like bacteria and viruses, called antigens. Antibodies, also known as ...

Earlier this year, Crossbow Therapeutics Inc. announced the nomination of its first development candidate, CBX-250, a TCR-mimetic (TCRm) bispecific T-cell engager (TCE) antibody targeting a CTSG ...

Despite being positive about DNA-based vaccine production in general, the study did identify areas in need of better ...

The lack of acute myeloid leukemia-specific antigens is one of the challenges for targeted immunotherapy together with on-target off-tumor toxicities due to the expression of the target in normal ...

Kumamoto University researchers have identified a powerful antibody that can neutralize a wide range of SARS-CoV-2 variants, ...

The global antibody drug conjugates market size was US$ 4,990.8 million in 2021. The global antibody drug conjugates s market size is forecast to reach US$ 33,150.3 million by 2030, growing at a CAGR ...

They work by exploiting the interactions between antibodies and their target antigens, making them crucial in applications ...